Andreu Parareda

691 total citations
18 papers, 436 citations indexed

About

Andreu Parareda is a scholar working on Neurology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andreu Parareda has authored 18 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 7 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andreu Parareda's work include Neuroblastoma Research and Treatments (10 papers), Ocular Oncology and Treatments (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). Andreu Parareda is often cited by papers focused on Neuroblastoma Research and Treatments (10 papers), Ocular Oncology and Treatments (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). Andreu Parareda collaborates with scholars based in Spain, Germany and Argentina. Andreu Parareda's co-authors include Jaume Mora, Carmen de Torres, Ofelia Cruz, Junne Kamihara, Lisa J. States, Michael F. Walsh, Garrett M. Brodeur, Sarah Scollon, Akira Nakagawara and Yaël P. Mossé and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Andreu Parareda

18 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreu Parareda Spain 10 154 136 126 115 112 18 436
S.P. Hector Spain 11 241 1.6× 51 0.4× 121 1.0× 81 0.7× 74 0.7× 25 455
Jiang Qian China 14 50 0.3× 194 1.4× 132 1.0× 57 0.5× 98 0.9× 53 465
Wijnanda A. Kors Netherlands 9 42 0.3× 187 1.4× 110 0.9× 79 0.7× 80 0.7× 19 415
Christopher B.O. Yu Hong Kong 13 52 0.3× 417 3.1× 138 1.1× 59 0.5× 130 1.2× 20 607
Nils Eide Norway 15 61 0.4× 451 3.3× 158 1.3× 61 0.5× 147 1.3× 41 595
Junyang Zhao China 7 31 0.2× 327 2.4× 128 1.0× 77 0.7× 149 1.3× 15 465
Lisa Shane United States 8 52 0.3× 52 0.4× 98 0.8× 85 0.7× 61 0.5× 14 283
David Sumerauer Czechia 12 107 0.7× 19 0.1× 171 1.4× 123 1.1× 125 1.1× 48 443
Noel Padrón‐Pérez Spain 13 73 0.5× 604 4.4× 143 1.1× 129 1.1× 243 2.2× 29 777
Steve Pakola Belgium 11 145 0.9× 285 2.1× 126 1.0× 52 0.5× 32 0.3× 20 528

Countries citing papers authored by Andreu Parareda

Since Specialization
Citations

This map shows the geographic impact of Andreu Parareda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreu Parareda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreu Parareda more than expected).

Fields of papers citing papers by Andreu Parareda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreu Parareda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreu Parareda. The network helps show where Andreu Parareda may publish in the future.

Co-authorship network of co-authors of Andreu Parareda

This figure shows the co-authorship network connecting the top 25 collaborators of Andreu Parareda. A scholar is included among the top collaborators of Andreu Parareda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreu Parareda. Andreu Parareda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kamihara, Junne, Franck Bourdeaut, William D. Foulkes, et al.. (2017). Retinoblastoma and Neuroblastoma Predisposition and Surveillance. Clinical Cancer Research. 23(13). e98–e106. 149 indexed citations
2.
Wasserman, Jonathan D., Gail E. Tomlinson, Harriet Druker, et al.. (2017). Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clinical Cancer Research. 23(13). e123–e132. 40 indexed citations
3.
Pascual‐Pasto, Guillem, Nagore G. Olaciregui, Mònica Vilà-Ubach, et al.. (2016). Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination. Cancer Letters. 380(1). 10–19. 24 indexed citations
4.
Mora, Jaume, Ofelia Cruz, Cinzia Lavarino, et al.. (2015). Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7). Clinical & Translational Oncology. 17(7). 521–529. 10 indexed citations
5.
Torrelo, Antonio, Asunción Vicente, Lara Navarro, et al.. (2014). Early‐onset acral basal cell carcinomas in Gorlin syndrome. British Journal of Dermatology. 171(5). 1227–1229. 9 indexed citations
6.
Grigorovski, Nathália, et al.. (2014). Use of intra-arterial chemotherapy for retinoblastoma: results of a survey.. SHILAP Revista de lepidopterología. 7(4). 726–30. 39 indexed citations
7.
Parareda, Andreu, Jaume Català, Ángel M. Carcaboso, et al.. (2013). Intra‐arterial chemotherapy for retinoblastoma. Challenges of a prospective study. Acta Ophthalmologica. 92(3). 209–215. 27 indexed citations
8.
Mora, Jaume, Carmen de Torres, Andreu Parareda, et al.. (2011). Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents. Pediatric Blood & Cancer. 57(1). 69–75. 11 indexed citations
9.
Mora, Jaume, Ofelia Cruz, Andreu Parareda, & Carmen de Torres. (2009). Treatment of Relapsed/Refractory Pediatric Sarcomas With Gemcitabine and Docetaxel. Journal of Pediatric Hematology/Oncology. 31(10). 723–729. 64 indexed citations
10.
Mora, Jaume, Ofelia Cruz, Andreu Parareda, Teresa Solá, & Carmen de Torres. (2009). Treatment of disseminated paraganglioma with gemcitabine and docetaxel. Pediatric Blood & Cancer. 53(4). 663–665. 6 indexed citations
11.
Mora, Jaume, María del Mar Pérez Gómez, Esther Geán, et al.. (2009). Axenfeld–Rieger ocular anomaly and retinoblastoma caused by constitutional chromosome 13q deletion. Pediatric Blood & Cancer. 54(3). 480–482. 5 indexed citations
12.
Cruz, Ofelia, Jaume Mora, Andreu Parareda, & Carmen de Torres. (2009). Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel. Journal of Clinical Oncology. 27(15_suppl). 10059–10059. 2 indexed citations
13.
Albert, Adrien, et al.. (2006). [The role of surgery for lung nodules in pediatric oncology].. PubMed. 19(4). 228–31. 1 indexed citations
14.
Parareda, Andreu, Soledad Gallego, Josep Roma, et al.. (2005). Prognostic impact of the detection of microcirculating tumor cells by a real-time RT-PCR assay of tyrosine hydroxylase in patients with advanced neuroblastoma. Oncology Reports. 14(4). 1021–7. 18 indexed citations
15.
Gallego, Soledad, Anna Llort, Andreu Parareda, & Joan Sánchez-de-Toledo. (2004). Expression of multidrug resistance-1 and multidrug resistance-associated protein genes in pediatric rhabdomyosarcoma. Oncology Reports. 11(1). 179–83. 7 indexed citations
17.
Vázquez, Élida, et al.. (2000). Subarachnoid-pleural fistula after resection of a thoracic ganglioneuroma: diagnosis by MRI and CT myelography. Pediatric Radiology. 30(8). 579–579. 4 indexed citations
18.
Gallego, Soledad, Andreu Parareda, Francina Munell, Joan Sánchez-de-Toledo, & Jaume Reventós. (1999). Clinical relevance of molecular markers in neuroblastoma: results from a single institution.. Oncology Reports. 6(4). 891–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026